Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Clostridium perfringens enterotoxin |
Is a |
True |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens alpha toxin |
Is a |
True |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens beta toxin |
Is a |
True |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens epsilon toxin |
Is a |
True |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens iota toxin |
Is a |
True |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens type C-antitoxin og Escherichia coli-antiserum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens type D-antitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens type C & D-toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens type D-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens type C-bakterintoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens type C & D-tetanustoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens type C-antitoxin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|
Clostridium perfringens type C-toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clostridium perfringens toxin |
Inferred relationship |
Some |
|